Fred van Leuven
Corporate Officer/Principal en Katholieke Universiteit Leuven .
Perfil
Fred van Leuven is the founder of AC Immune SA and reMYND NV, both founded in 2003 and 2002 respectively.
He is currently a Professor at Katholieke Universiteit Leuven.
Dr. van Leuven received a doctorate degree from Ghent University in 1976 and a graduate degree from the same university in 1970.
Cargos activos de Fred van Leuven
Empresas | Cargo | Inicio |
---|---|---|
Katholieke Universiteit Leuven | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Fred van Leuven.
Empresas | Cargo | Fin |
---|---|---|
AC IMMUNE SA | Fundador | - |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Fundador | - |
Formación de Fred van Leuven.
Ghent University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AC IMMUNE SA | Health Technology |
Empresas privadas | 1 |
---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Bolsa de valores
- Insiders
- Fred van Leuven